SA’s biggest pharmaceutical manufacturer, Aspen Pharmacare, has agreed to sell six prescription drugs to Swiss group Acino for R1.8bn, part of its strategy to refine its portfolio and reduce debt.

The medicines are used for the treatment of gastroenterology, erectile dysfunction and cardiovascular diseases, and generated R512m in revenue in Aspen’s 2021 year — about 1.3% of the group's...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now